Tenax Therapeutics (TENX) Misses Q2 EPS by 27c

Tenax Therapeutics (NASDAQ: TENX) reported Q2 EPS of ($0.27).

For earnings history and earnings-related data on Tenax Therapeutics (TENX) click here.

You May Also Be Interested In

• Needham Starts Red Violet (RDVT) at Buy, 'offers the leading Cloud identity intelligence platform in the market today'
• Scotiabank Starts Perpetua Resources (PPTA) at Sector Outperform
• Stocks expected to have increasing option volume: DELL PANW SNOW AVGO MDT